Operating margin went from 18% to 25% while the highest-margin revenue line fell 12% and backlog grew at a third of the revenue rate.
Thesis: Operating leverage here is real and verified in dollars: $15M operating profit vs $8.6M a year ago while the lowest-margin stream shrank, so gross margin holding at 76% speaks to scale, not mix. But backlog grew 9% against 26% revenue growth, part of that growth is a SecureWise anniversary lap, cash fell $11M into a $10M eProbe build, and reconfirmed 20% guidance from a 26% Q1 prices deceleration. The numbers earn a hold, not a size-up.
Verdict: HOLD — Conviction: MEDIUM
Catalyst: Q2 eProbe revenue recognition starting on the shipped unit plus Characterization/DFI bookings converting as advanced process development ramps, and the Q3 beta of AI-enabled Exensio.
Key Risk: Top three customers were 53% of 2025 revenue and management expects repeat customers to carry the bigger dollar bookings. One renewal slip or eProbe missing the six-unit ship target breaks the growth and CapEx case simultaneously.
The Tell: Asked how much of the eProbe pipeline is net new, Kibarian volunteered the downside unprompted: 'maybe not all of them directly contributing to revenue this year. One of them will be a demo machine, so probably five of the six will be revenue generating.' Pre-lowering his own six-unit guide on a routine pipeline question.
Friction Level: MODERATE_FRICTION — Both sides agree on the numbers. The disagreement is whether 26% revenue growth with 9% backlog growth is acceleration or a flattered print driven by a full quarter of SecureWise plus pre-bought Symmetrix runtime licenses, with reconfirmed 20% guidance implying back-half deceleration.
2026Q1 · May 7, 2026
5 of 5 readings agreed5 HOLDRead the full call
Backlog Up 9%, Revenue Up 26%, Guide Held at 20%
Operating leverage here is real and verified in dollars: $15M operating profit vs $8.6M a year ago while the lowest-margin stream shrank, so gross margin holding at 76% speaks to scale, not mix. But backlog grew 9% against 26% revenue growth, part of that growth is a SecureWise anniversary lap, cash fell $11M into a $10M eProbe build, and reconfirmed 20% guidance from a 26% Q1 prices deceleration. The numbers earn a hold, not a size-up.
Asked how much of the eProbe pipeline is net new, Kibarian volunteered the downside unprompted: 'maybe not all of them directly contributing to revenue this year. One of them will be a demo machine, so probably five of the six will be revenue generating.' Pre-lowering his own six-unit guide on a routine pipeline question.
Gross margin held at 76% while volume-based revenue fell 12% to $9.2M on lower gainshare, and operating margin moved from 18% to 25% year over year. Scale is offsetting the loss of the highest-margin stream.
$10M of Q1 CapEx funded from operations into eProbe builds to hit the six-machine ship guide, with the revolver expanded to $30M after quarter close to back further build.
Intel standardized on SecureWise publicly, Symmetrix runtime licenses are being pre-purchased ahead of machine shipments, and Exensio booked an enterprise-wide Test deployment at a large IDM. Retained installs compound.
Backlog of $246M grew 9% while revenue grew 26%, and part of the Symmetrix booking strength is customers pre-buying runtime licenses in anticipation of future machine shipments. Pull-forward against an uncertain machine pipeline.
eProbe is gated by PDF's own manufacturing pace: one of six machines shipped in Q1, one is a demo with no revenue, and management concedes not all six contribute this year. Pipeline exceeds build rate.
The AI-enabled Exensio release is a Q3 beta, SecureWise OSAT and fabless expansion is pilot status, and the CEO's 100th-call 'most interesting time ever' framing runs ahead of booked AI revenue.
+62
CONFIDENT"Management gave specific numbers unprompted: six machines, five revenue-generating, one demo, 10 of 12 subscribed, $10M CapEx, 27% target. Kibarian volunteered the eProbe caveat before being pushed. One hedge only: 'How much sooner—we are not quite ready, Ben, to say.'"
Full transcript with segment-level revenue, backlog, cash, CapEx, and customer concentration disclosed. Analysts pressed on margin quality, backlog, and eProbe conversion and got direct answers with numbers.
Q2 eProbe revenue recognition starting on the shipped unit plus Characterization/DFI bookings converting as advanced process development ramps, and the Q3 beta of AI-enabled Exensio.
Top three customers were 53% of 2025 revenue and management expects repeat customers to carry the bigger dollar bookings. One renewal slip or eProbe missing the six-unit ship target breaks the growth and CapEx case simultaneously.
“Total revenue for the first quarter was $60.1 million, up 26% versus the same quarter of last year.”
Changed less than 77% of calls
Wording compared with the Feb 12, 2026 call, ranked among 97 calls reporting on Q1 2026. A measure of how much the story moved, not a signal about the stock.
Figures are extracted from the transcripts and checked in code: every quote appears word for word. Language change is computed from word frequencies, with no model involved. Descriptive only: none of this feeds the verdict.
Revenue up 26% to $60.1M with operating profit up 75% to $15M and operating margin at 25% against a 27% target set only in December. Gross margin held at 76% while gainshare, the highest-margin line, fell 12%, which means scale is doing the work, not mix. Opex scaling below revenue is the classic early-stage leverage signature. Intel standardizing on SecureWise is a named enterprise proof point, not a pilot. eProbe subscription base roughly doubles to 10 of 12 machines this year, building a recurring floor on top of retained installs. $10M of self-funded CapEx into machines management can see demand for. The Street still models 20% growth, 20% op margin. It is wrong on the margin trajectory.
The 36% Platform growth includes a full quarter of SecureWise against a partial one last year, so the organic rate sits below the headline. Backlog grew 9% while revenue grew 26%, and some of that backlog is Symmetrix customers pre-buying runtime licenses against machines that have not shipped. One of six eProbe units shipped in Q1, one is a demo with zero revenue, and management concedes not all will contribute this year. Cash fell from $42M to $31M in a quarter with $15M of operating profit because $10M went into building machines, and the revolver was expanded to $30M after the close. Guidance reconfirmed at 20% off a 26% Q1 embeds deceleration. Top three customers are 53% of revenue and management says repeat customers carry the bigger dollar bookings. Volume-based revenue, 'the least in our control' per CFO Raza, is falling.
Backlog Quality
Backlog of $246M grew 9% against 26% revenue growth. Symmetrix strength came partly from customers pre-buying runtime licenses ahead of future machine shipments, which is pull-forward against a pipeline where only one of six eProbe units shipped.
Capacity Ceiling
Six-machine eProbe goal with one shipped, one demo unit with no revenue, and management stating 'maybe not all of them directly contributing to revenue this year.' Installed base doubling depends entirely on PDF's own build execution.
AI Label Without Substance
AI-enabled Exensio is a Q3 beta, SecureWise expansion to OSATs and fabless is on pilot, and the CEO's 'most interesting time I have ever seen' framing on his 100th call is narrative running ahead of booked dollars.
Unsustainable Trend Confidence
A 26% quarter against reconfirmed 20% full-year guidance, flattered by a SecureWise anniversary effect, with management signaling targets hit faster than model. Confidence is built on one print plus one acquisition lap.
HOLD at moderate conviction. The operating leverage is real and dollar-verified, so I will not short quality. But backlog lagging revenue by 17 points, a SecureWise anniversary lap inside the 36% Platform number, $11M of cash burn into an unshipped machine build, and a 20% guide off a 26% quarter mean the street is being asked to pay up for deceleration. Wait for two data points: Q2 eProbe revenue recognition and backlog/revenue growth converging above 15%. Long on a Q2 beat with backlog growth re-accelerating; short only if a top-three renewal slips or the six-unit eProbe target drops.